Cumberland Pharmaceuticals
CPIX
40 hedge funds and large institutions have $27.1M invested in Cumberland Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 5 closing their positions.
15% more capital invested
Capital invested by funds: $23.6M → $27.1M (+$3.51M)
4% less call options, than puts
Call options by funds: $115K | Put options by funds: $120K
9% less funds holding
Funds holding: 44 → 40 (-4)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$917K |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$269K |
| 3 |
Renaissance Technologies
New York
|
+$55.5K |
| 4 |
Invesco
Atlanta,
Georgia
|
+$9.41K |
| 5 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$9.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$145K |
| 2 |
SIM
Spark Investment Management
New York
|
-$65.4K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$58K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$54.8K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$44.8K |
CPIX Hedge Fund Activity: Q3 2016 in Review
40 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2016, worth a combined $27.1M — up 15% from $23.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CPIX and 1 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 11 added.
The largest buyer was Stonepine Capital Management, adding an estimated $917K. The largest seller was Eagle Global Advisors, cutting an estimated $145K.
- 40 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2016, down from 44 in Q2 2016.
- Funds reported $27.1M of Cumberland Pharmaceuticals stock for Q3 2016, up 15% quarter-over-quarter.
- 1 fund opened new Cumberland Pharmaceuticals positions in Q3 2016 and 5 closed out, a net change of -4 holders.
- The largest Cumberland Pharmaceuticals buyer in Q3 2016 was Stonepine Capital Management, an estimated $917K added.
- The largest Cumberland Pharmaceuticals seller in Q3 2016 was Eagle Global Advisors, an estimated $145K sold.
Based on aggregated 13F filings for Q3 2016.